Ovoca Bio | OVG - Interest Expense On Debt


Ovoca Bio reported EUR7K in Interest Expense on Debt for its fiscal semester ending in June of 2022.





Interest Expense On Debt Change Date
Akebia Therapeutics 362.52M 357.69M Mar/2026
Alaunos Therapeutics USD 1.07M 215K Jun/2023
ALKERMES USD 25.92M 5.03M Jun/2026
Avita Medical AUD 1.25M 100K Jun/2025
Dianthus Therapeutics USD 4.44M 263K Sep/2024
Ionis Pharmaceuticals USD 18M 1000K Jun/2026
IQVIA Holdings USD 197M 5M Jun/2026
Moderna USD 10.96B 527M Jun/2026
Organon & Co USD 111M 17M Mar/2026
Ovoca Bio EUR 7K 6K Jun/2022
Revvity USD 22.99M 1.73M Jun/2026
Tectonic Therapeutic USD 246.58M 246.56M Mar/2026
Viatris USD 120.1M 500K Mar/2026
Xeris Pharmaceuticals USD 6.88M 269K Mar/2026